We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Crism Therapeutics Corp | AQSE:AMC.GB | Aquis Stock Exchange | Ordinary Share | VGG042401262 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 8.00 | 14.00 | 11.00 | 11.00 | 11.00 | 0.00 | 06:59:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMC
RNS Number : 5569F
Amur Minerals Corporation
07 November 2022
7 November 2022
AMUR MINERALS CORPORATION
(AIM: AMC)
Transaction Update
Amur Minerals Corporation ("Amur" or the "Company") takes this opportunity to update shareholders on the status of the Company's disposal of its AO Kun-Manie wholly owned subsidiary to Bering Metals LLC (the "Buyer"), a Russian incorporated company. Totaling US$35 million, the transaction was anticipated for completion in early November 2022.
However Western introduced restrictions related to the international transfer of funds from the Russian Federation have become more restrictive with time. Mainstream international banks are severely restricting or are no longer allowing such transactions per their internal compliance protocols. This includes the Company's bank which has necessitated establishing alternative banking services. The Buyer and the Company are coordinating efforts to establish a fully compliant fund transfer allowing for completion.
Robin Young, CEO of Amur, commented:
"Amur and Bering are keen to complete the sale of AO Kun-Manie as soon as possible. The majority of our efforts are focused on establishing a chain of custody for the fund transfer which is fully compliant with the current geopolitical situation. We look forward to updating shareholders once the banking restrictions are successfully solved. With regard to timing, this is dependent upon banking institutions completion of their Know Your Client ("KYC") protocols."
Market Abuse Regulation (MAR) Disclosure)
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Company Nomad and Broker Public Relations Amur Minerals S.P. Angel Corporate BlytheRay Corp. Finance LLP Robin Young CEO Richard Morrison Megan Ray Adam Cowl Tim Blythe +44 (0) 7981 126 +44 (0) 20 7138 818 +44 (0) 20 3470 0470 3203
For additional information on the Company, visit the Company's website, www.amurminerals.com .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBXBDBXXGDGDR
(END) Dow Jones Newswires
November 07, 2022 08:37 ET (13:37 GMT)
1 Year Crism Therapeutics Chart |
1 Month Crism Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions